J. Edelman

发表

The SARS-CoV-2 effective reproduction rate has a high correlation with a contact index derived from large-scale individual location data using GPS-enabled mobile phones in Germany

Jonathan A. Edelman, S. Konigorski, S. Rüdiger, 2020, medRxiv.

Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults.

I. Smolenov, Bin Zhang, Carlos Fierro, 2020, Vaccine.

Outcomes in Pregnant Persons Immunized with a Cell-Based Quadrivalent Inactivated Influenza Vaccine: A Prospective Observational Cohort Study

J. Albano, H. Tilson, M. Hohenboken, 2022, Vaccines.

A Prospective Cohort Study on Pregnancy Outcomes of Persons Immunized with a Seasonal Quadrivalent Inactivated Influenza Vaccine during Pregnancy

J. Albano, M. Hohenboken, J. Oberyé, 2022, Vaccines.

Safety, Immunogenicity, and Efficacy of a COVID-19 Vaccine (NVX-CoV2373) Co-administered With Seasonal Influenza Vaccines

G. Glenn, A. Goodman, J. Galloway, 2021, medRxiv.

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

Adam C. Champion, Jane E. Ewing, M. Elnaggar, 2021, The Lancet Respiratory Medicine.

Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.

I. Smolenov, L. Bravo, T. Nolan, 2021, The New England journal of medicine.

Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial.

M. Hohenboken, Robert J. Jeanfreau, D. Molrine, 2022, Pediatrics.

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59 months of age: A phase 3, randomized, noninferiority study.

E. Heijnen, Daphne C Sawlwin, Victoria A Statler, 2019, Vaccine.

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.

P. Pitisuttithum, H. Reynales, I. Smolenov, 2021, The Lancet. Infectious diseases.

Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial

Steven Bird, M. Schatz, E. Orav, 2005 .